Work

Brexucabtagene autoleucel for relapsed/refractory mantle cell lymphoma: Real-world experience from the United States lymphoma CAR T consortium.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.16_suppl.e19583

Authors: Preetesh Jain, Yucai Wang, Frederick L. Locke, Javier Munoz, Amer Beitinjaneh, Matthew Joshua Frank, Saurabh Dahiya, Miriam T. Jacobs, Brian T Hill, Lazaros J. Lekakis, David Bernard Miklos, Armin Ghobadi, Sattva Swarup Neelapu, Yi Lin, Michael Wang, Michael D. Jain, Matthew J. Maurer

Institutions: The University of Texas MD Anderson Cancer Center, Mayo Clinic, Moffitt Cancer Center, Mayo Clinic in Arizona, University of Miami, Stanford University, Baystate Medical Center, Washington University in St. Louis, Cleveland Clinic, Sylvester Comprehensive Cancer Center, Stanford Medicine

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4281932129

Cites:

Cited by: 6

Related to: 10